Combined Nutritional and Exercise Strategies to Reduce Liver Fat Content in Patients With Type 2 Diabetes

December 3, 2012 updated by: rivellese angela, Federico II University
The aim of this study will be to evaluate in patients with type 2 diabetes the effects on liver fat of an intervention with a diet relatively rich in CHO/rich in fibre/low GI or a diet rich in MUFA, either combined or not with a structured program of physical exercise, with emphasis on mechanisms possibly underlining these effects, namely changes in postprandial triglyceride-rich lipoproteins, body fat distribution, insulin sensitivity, oxidative stress and inflammation, adipose tissue lipolytic activities, aerobic capacity and endothelial function.

Study Overview

Study Type

Interventional

Enrollment (Actual)

45

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

35 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Men and postmenopausal women
  • Age 35-65 years
  • BMI 27- 34 kg/m2
  • HbA1c <8%
  • Fasting plasma cholesterol <250 mg/dl
  • Fasting plasma triglycerides <300 mg/dl

Exclusion Criteria:

  • Hypolipidemic drugs
  • Plasma creatinine >1.7 mg/dl transaminases > 2 norma values
  • Ischemic heart disease or positive treadmill stress test
  • High intensity regular physical activity
  • Any disease or chronic or/and acute condition contraindicating physical activity(anaemia, and infectious, neoplastic, neurological and osteoarticular diseases).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: high fibre/low glycemic index diet - P A
patients will follow for two months a diet high fibre/low glycemic index without physical activity program
Patients will follow for two months a high fibre/low glycemic index diet without a physical activity program.
Active Comparator: Rich in MUFA diet - PA
Patients will follow for two months a rich in MUFA diet without a physical activity program.
The patients will follow a rich in MUFA diet without a physical activity program.
Active Comparator: high fibre/low glycemic index diet+PA
Patients will follow for two months a high fibre and low glycemic index diet associated with a physical activity program.
patients will follow for two months a high fibre/ low glycemic index diet with a physical activity program.
Active Comparator: Rich in MUFA diet+PA
Patients will follow for 2 months a rich in MUFA diet with a physical activity program.
Patients will follow for two months a rich in MUFA diet with a physical activity program.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Liver fat content
Time Frame: 0 and 8 weeks
0 and 8 weeks
postprandial lipids metabolism
Time Frame: 0 and 8 weeks
0 and 8 weeks

Secondary Outcome Measures

Outcome Measure
Time Frame
changes in body fat distribution
Time Frame: 0 and 8 weeks
0 and 8 weeks
oxidative stress and inflammation
Time Frame: 0 and 8 weeks
0 and 8 weeks
adipose tissue lipolytic activities
Time Frame: 0 and 8 weeks
0 and 8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2009

Primary Completion (Actual)

September 1, 2011

Study Completion (Actual)

September 1, 2011

Study Registration Dates

First Submitted

December 2, 2009

First Submitted That Met QC Criteria

December 3, 2009

First Posted (Estimate)

December 4, 2009

Study Record Updates

Last Update Posted (Estimate)

December 5, 2012

Last Update Submitted That Met QC Criteria

December 3, 2012

Last Verified

December 1, 2012

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Type 2 Diabetes

Clinical Trials on High fibre/low glycemic index diet-PA

3
Subscribe